School of Medicine
Showing 1-10 of 47 Results
-
Robert Michael Fairchild
Assistant Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsDr. Fairchild’s research interests center on novel applications of ultrasonography in rheumatologic disease. Current active research endeavors include using ultrasound 1) to evaluate articular and soft tissue manifestations of systemic sclerosis, 2) to screen, detect and monitor of connective tissue disease associated interstitial lung disease, 3) and applying deep learning techniques to rheumatology ultrasound and imaging.
-
Bita Fakhri, MD, MPH
Assistant Professor of Medicine (Hematology)
BioDr. Bita Fakhri is Assistant Professor of Medicine in the Division of Hematology at Stanford University School of Medicine. She specializes in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), hairy cell leukemia, and other hematologic malignancies. As a clinical scientist, Dr. Fakhri is dedicated to caring for patients, teaching trainees, and researching novel therapies for patients with CLL/SLL. Dr. Fakhri has co-authored numerous publications on topics including CLL, novel targeted agents, and cellular therapies for patients with hematologic malignancies. Currently, Dr. Fakhri is the director of the CLL clinical trial portfolio at Stanford. Additionally, in her role as the DEI ambassador of the Division of Hematology, her main focus is to enhance trial equity among underserved and marginalized populations in the Stanford catchment area.
-
Titilola Falasinnu
Assistant Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)
BioI am primarily a lupus researcher and identify as a pain scientist and methodologist in this field. Systemic lupus erythematosus (SLE) disproportionately affects women and racial minorities and is the fifth most common cause of death among 15- to 24-year-old Black and Hispanic women in the U.S., highlighting its significant public health impact. More than half of patients with SLE experience chronic pain, often secondary to SLE itself or overlapping conditions (e.g., migraines, low back pain, fibromyalgia), contributing significantly to disability and impaired quality of life. Chronic pain is not merely a symptom but a disease in its own right—one that deserves the same rigorous study and clinical attention as comorbidities like kidney disease and cardiovascular disease in rheumatology. The enormous global burden of chronic pain underscores the urgent need for a clear, standardized definition of pain as a disease, particularly in autoimmune rheumatic diseases where pain can arise from inflammatory, nociplastic, and biopsychosocial mechanisms. Without recognizing pain as a distinct disease entity, its mechanisms remain poorly understood, and effective treatment strategies remain underdeveloped.
I am a co-Principal Investigator of the Pain Intelligence Lab, where our mission is to advance the study of pain as a disease in rheumatology through two primary objectives. First, we develop and validate computational methods that enable clinicians and researchers to leverage electronic health records, administrative claims, and disease registries to study chronic pain as a distinct disease entity in rheumatology. By applying machine learning, natural language processing, and real-world data analysis, we seek to enhance pain phenotyping, classify distinct pain subtypes, and develop predictive models for treatment response. Second, we use a biopsychosocial framework to examine the predictive power of biomarkers and psychosocial measures in rheumatologic pain. By integrating biological, psychological, and social determinants of pain, we aim to conduct rigorous, patient-oriented research that translates targeted assessments into mechanistically informed, personalized treatment approaches for optimized clinical care. Ultimately, my long term career goal is to bridge the gap between research and clinical practice, ensuring that pain management in autoimmune rheumatic diseases is precise, equitable, and optimized for improved patient outcomes. -
Alice C. Fan
Associate Professor of Medicine (Oncology) and, by courtesy, of Urology
Current Research and Scholarly InterestsDr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
-
Diana Farid
Clinical Associate Professor, Medicine - Vaden Health Center
BioDiana Farid MD, MPH is a physician, award-winning author, poet, and filmmaker. She is a staff physician at the Stanford Vaden Health Center and Clinical Associate Professor in the Department of Medicine. She holds a BA in Peace and Conflict Studies from Berkeley, with a concentration in public health, socio-economic development, and human rights. She was awarded a fellowship by the Maternal and Child Health Bureau, U.S. Department of Health and Human Services, to be a Child and Family Health Leadership Fellow at UCLA, where she also earned a Masters in Public Health focused on community health, health communications, and storytelling.
She creates and amplifies stories and art to foster health.
As a physician consultant for The Media Project, Advocates for Youth, Diana worked with writers and producers for TV shows, such as GREY’S ANATOMY and STRONG MEDICINE, to promote adolescent health through entertainment. Her debut feature length documentary film production, AMERICAN RHYTHMS (2008) (americanrhythmsmovie.com/), explores the positive impact of music on elementary school students.
She has lead or presented at Medical Humanities and Arts programs across Stanford, including annual readings of her original poetry in collaboration with the St. Lawrence String Quartet, leading The Pegasus Writers' "The Body as Temple" curated reading, and leading Medicine and the Muse's annual collaboration with UNAFF, among others. As the first Assistant Director of Stanford School of Medicine’s Program in Bioethics and Film, she produced film screenings and panel discussions with producers, directors, field experts, Stanford faculty, students, and the community, exploring films with vital bioethical implications. She established the first Stanford Film and Medicine Interest group for medical students to study film as a health promotion tool and has mentored medical student film projects. She was a lead producer of the Stanford Medicine and the Muse/Medical Humanities and the Arts' 2018 Frankenstein@200 year-long cross-campus film screening series and speaker panels on the personal, cultural, social, and bioethical impact of medical research, technology, and healthcare through the lens of story in film. Currently, she mentors Medical Humanities and Art Faculty Fellows.
Diana’s poems have been presented in anthologies, journals, gallery exhibits, and live story telling events, including The Nocturnists. Her poem, "Dear Medicine", is part of the seminal 2019 report by the National Academy of Medicine, “Taking Action Against Clinician Burnout”. She is an Editorial Board member of the medical humanities journal, The Pharos.
Her multi-award winning picture book, WHEN YOU BREATHE, melds respiratory science with poetry. Her multi-award winning novel WAVE, noted as “Raw and powerful…Rich, layered and heart-rending” — Kirkus, won the Cybils Award for Novel in Verse and was named a Best Middle Grade Book of 2022 by the School Library Journal. WAVE highlights the power of poetry and music on wellbeing. Her 2024 books, THE LIGHT OF HOME and ALREADY ALL THE LOVE, celebrate home and presence. -
C. Garrison Fathman
Professor of Medicine (Immunology and Rheumatology), Emeritus
Current Research and Scholarly InterestsMy lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We have identified and characterized a gene (GRAIL) that seems to control regulatory T cell (Treg) responsiveness by inhibiting the Treg IL-2 receptor desensitization. We have characterized a gene (Deaf1) that plays a major role in peripheral tolerance in T1D. Using PBC gene expression, we have provisionally identified a signature of risk and progression in T1D.
-
William Fearon, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Fearon's general research interest is coronary physiology. In particular, he is investigating invasive methods for evaluating the coronary microcirculation. His research is currently funded by an NIH R01 Award.
